Alzheimer disease therapy: can the amyloid cascade be halted?
about
Tramiprosate (Alzhemed) for Alzheimer's diseaseBRI2 (ITM2b) inhibits Abeta deposition in vivoNSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivoHis-tag binding by antibody C706 mimics β-amyloid recognitionModular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies.Changing the course of Alzheimer's disease: anti-amyloid disease-modifying treatments on the horizon.A small molecule inhibitor of signal peptide peptidase inhibits Plasmodium development in the liver and decreases malaria severity.Search strategies used by APP transgenic mice during navigation in the Morris water maze.Apolipoprotein E: from lipid transport to neurobiologyModerate alcohol consumption and cognitive riskSuppressed retinal degeneration in aged wild type and APPswe/PS1ΔE9 mice by bone marrow transplantationNeurodegeneration: what is it and where are we?Cholesterol: from heart attacks to Alzheimer's disease.Theta and alpha EEG frequency interplay in subjects with mild cognitive impairment: evidence from EEG, MRI, and SPECT brain modifications.Future directions in the treatment of Alzheimer's disease.Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin.Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?Genomic characterization of Alzheimer's disease and genotype-related phenotypic analysis of biological markers in dementia.Chemical Biology, Molecular Mechanism and Clinical Perspective of γ-Secretase Modulators in Alzheimer's DiseaseStigmatization in Alzheimer's disease research on African American elders.Genetic basis of Alzheimer's dementia: role of mtDNA mutations.Gamma-secretase modulation with Abeta42-lowering nonsteroidal anti-inflammatory drugs and derived compounds.Disease modifying therapy for AD?In Vivo Detection of Amyloid Plaques by Gadolinium-Stained MRI Can Be Used to Demonstrate the Efficacy of an Anti-amyloid ImmunotherapyAmyloid precursor protein and presenilin involvement in cell signaling.Looking for novel ways to treat the hallmarks of Alzheimer's disease.Targeting insulin-like growth factor-1 to treat Alzheimer's disease.Apolipoprotein E and cholesterol in aging and disease in the brainAbeta42 neurotoxicity in primary co-cultures: effect of apoE isoform and Abeta conformation.Early diagnosis and treatment of Alzheimer's disease.5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's diseaseIncrease of theta frequency is associated with reduction in regional cerebral blood flow only in subjects with mild cognitive impairment with higher upper alpha/low alpha EEG frequency power ratio.Modeling familial British and Danish dementia.An update on clinical proteomics in Alzheimer's research.Gelsolin as therapeutic target in Alzheimer's disease.Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood-brain barrier model.The Protective Effects of Icariin against the Homocysteine-Induced Neurotoxicity in the Primary Embryonic Cultures of Rat Cortical Neurons.Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer's Disease.MCP-1 involvement in glial differentiation of neuroprogenitor cells through APP signaling
P2860
Q24240273-0945945F-AA69-4D3B-920C-856F71F5A337Q24319041-E64B8B2A-4654-4B90-92F5-735020E844BBQ24679444-EC76C7AC-ACDA-4D29-AB9C-B3B728D041C9Q27664463-B2DF8D9D-5329-496C-8030-A4A9906D8773Q30881498-DA12D1D0-1623-474B-B729-959007CE70ADQ33289262-2CE22351-1232-4EE9-8AF3-3B676A40DAB0Q33425212-10337774-1A74-47AA-9CFA-037576ACD679Q34340670-5684E693-B154-432D-8239-632928C6F50DQ34497951-ABA055FA-4BEF-4BAC-B49C-46EA44402BB3Q34631760-42153F82-6601-4D46-AF59-0B988E2E24E1Q34764098-C15B556D-AD97-4114-A8C4-F205F3F18A2FQ34828270-C6AF0D02-BD83-461F-B640-BFD160AA2619Q35167628-043AF3FD-A351-44FC-834E-04A7D047F6BFQ35409410-6C157312-D818-40F0-8E10-454DF8256AD5Q35753450-A450A193-01E2-4F6F-8983-03A5A1A7A457Q35806684-BE661DBB-0EE2-4C7B-93A8-BD0B725938C5Q35825892-BBB840E5-50E7-4823-97FC-48C276C045E5Q35976397-F47E0757-303F-4668-84FA-0575F32FAF42Q36081889-B728862E-4683-4498-97AE-8C87AB883ECFQ36311710-55918999-A30C-4AE7-BA73-81E16D5BF853Q36471814-EE7DA7CB-AA25-424C-ACED-0EA9791822B4Q36626447-628AE1DE-C967-4B3E-B9B4-F4B654A76E95Q36640414-FC0A8FB7-5A0E-425B-B632-CE07C436B342Q36715449-E15353FE-F0AA-4B11-A139-CEE77B970A84Q36863026-3CAD77DF-FABA-4711-A431-FB1139009008Q36904846-A93E07E0-C247-4224-A7EB-AC8F1AE89D39Q37004725-E7FD6B42-69EE-4B97-9690-2A77DB1CBA68Q37009967-541D24D4-F1CD-46E6-9976-81E0F26C689AQ37119890-398B6BD9-9DC1-440F-80CE-33F7935BD37AQ37154809-CCF89437-94DE-45F4-BE5F-5EC91373A81FQ37232572-DF0F3924-2119-4D9C-956D-5241C825B17AQ37365365-5A3AE1CE-AB51-419F-B309-AB0707B7F1C9Q37603090-F1C9CAE1-D197-426F-A4D6-7BE6DBCFE6BBQ37668720-9384C86B-447B-49D2-AC35-F24BFBAE3AAEQ37740141-2CC93267-8288-48A9-B6C9-8330FF67A305Q38002023-27CED93E-810A-467F-A66B-6468BD5D0105Q38647131-43AA32B4-3213-4535-B517-A016DF56446FQ38791608-8818DA27-1B8A-4AFE-8A8F-4635544EEB09Q39757268-A8B47C5E-83B1-49DB-B21A-7686F2CC8070Q39888649-49E8A845-65F9-4FAD-8A8F-8E040792820F
P2860
Alzheimer disease therapy: can the amyloid cascade be halted?
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Alzheimer disease therapy: can the amyloid cascade be halted?
@ast
Alzheimer disease therapy: can the amyloid cascade be halted?
@en
Alzheimer disease therapy: can the amyloid cascade be halted?
@nl
type
label
Alzheimer disease therapy: can the amyloid cascade be halted?
@ast
Alzheimer disease therapy: can the amyloid cascade be halted?
@en
Alzheimer disease therapy: can the amyloid cascade be halted?
@nl
prefLabel
Alzheimer disease therapy: can the amyloid cascade be halted?
@ast
Alzheimer disease therapy: can the amyloid cascade be halted?
@en
Alzheimer disease therapy: can the amyloid cascade be halted?
@nl
P2860
P356
P1476
Alzheimer disease therapy: can the amyloid cascade be halted?
@en
P2093
Todd E Golde
P2860
P356
10.1172/JCI200317527
P407
P577
2003-01-01T00:00:00Z